Literature DB >> 23661235

Reference intervals of α-glycosidase, β-glycosidase, and α-galactosidase in dried blood spot in a Turkish newborn population.

Ozan Aldemir1, Pelin Ergun, Sezgin Güneş, Ozge Altun Köroğlu, Mehmet Yalaz, Nilgün Kültürsay, Mahmut Coker, Eser Y Sözmen.   

Abstract

Inherited lysosomal storage diseases (LSDs) are rare, and diagnosis is often delayed for 7-10 years. Since the therapies have become available for a limited number of LSDs, (Fabry, Gaucher, Pompe, and MPS-1), early diagnosis of treatable LSDs can be lifesaving or ameliorating and allows timely treatment before irreversible damage occurs. Recently, the use of dried blood spot test (DBS) for newborn screening of LSDs has been proposed for newborn screening tests. They are noninvasive, sensitive, and specific assays with the further advantage of a fast turnaround time compared to measurement in leukocyte and/or fibroblast culture. We aimed to determine the reference intervals for lysosomal enzyme activities of newborn babies in our population and to investigate the effect of gestational week on enzyme activity. One hundred thirty healthy newborn babies (70 girls, 60 boys) were included into the study. α-Glycosidase, β-glycosidase, and α-galactosidase activities in DBS samples of newborns were determined fluorometrically. Reference intervals were calculated using Dixon's rule and percentiles of 2.5-97.5. Cutoff limits (5 %) for α-glycosidase, β-glycosidase, and α-galactosidase activities were 0.57, 0.92, and 2.18, respectively. α-Galactosidase activity was higher in girls compared to boys (p < 0.05). Interestingly, α-glycosidase and β-glycosidase activities of newborns who were delivered before 38 weeks were significantly lower than those who were delivered at 39-40 weeks. Conclusion It is of utmost importance to define the reference intervals for lysosomal enzyme activities as well as cutoff limits for newborn babies with regard to gestational age and sex. More studies to clarify the reason for the change in enzyme activity by gestational week will be required.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23661235     DOI: 10.1007/s00431-013-2026-3

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  20 in total

1.  Fabry disease: enzymatic diagnosis in dried blood spots on filter paper.

Authors:  N A Chamoles; M Blanco; D Gaggioli
Journal:  Clin Chim Acta       Date:  2001-06       Impact factor: 3.786

Review 2.  Reference intervals: an update.

Authors:  Paul S Horn; Amadeo J Pesce
Journal:  Clin Chim Acta       Date:  2003-08       Impact factor: 3.786

3.  Sample blank subtraction outreachs hemoglobin interferences in flurorometric methods for DBS.

Authors:  Eser Y Sozmen
Journal:  Mol Genet Metab       Date:  2011-12-24       Impact factor: 4.797

4.  Neonatal screening for lysosomal storage disorders: feasibility and incidence from a nationwide study in Austria.

Authors:  Thomas P Mechtler; Susanne Stary; Thomas F Metz; Víctor R De Jesús; Susanne Greber-Platzer; Arnold Pollak; Kurt R Herkner; Berthold Streubel; David C Kasper
Journal:  Lancet       Date:  2011-11-29       Impact factor: 79.321

Review 5.  Newborn screening of lysosomal storage disorders.

Authors:  Deborah Marsden; Harvey Levy
Journal:  Clin Chem       Date:  2010-05-20       Impact factor: 8.327

6.  Twelve different enzyme assays on dried-blood filter paper samples for detection of patients with selected inherited lysosomal storage diseases.

Authors:  Gabriel Civallero; Kristiane Michelin; Jurema de Mari; Marli Viapiana; Maira Burin; Janice C Coelho; Roberto Giugliani
Journal:  Clin Chim Acta       Date:  2006-05-18       Impact factor: 3.786

Review 7.  The use of dried blood spot samples in the diagnosis of lysosomal storage disorders--current status and perspectives.

Authors:  Arnold J Reuser; Frans W Verheijen; Deeksha Bali; Otto P van Diggelen; Dominique P Germain; Wuh-Liang Hwu; Zoltan Lukacs; Adolf Mühl; Petra Olivova; Monique Piraud; Birgit Wuyts; Kate Zhang; Joan Keutzer
Journal:  Mol Genet Metab       Date:  2011-07-23       Impact factor: 4.797

8.  Newborn screening for lysosomal storage disorders.

Authors:  Peter J Meikle; Dallas J Grasby; Caroline J Dean; Debbie L Lang; Michelle Bockmann; Alison M Whittle; Michael J Fietz; Henrik Simonsen; Maria Fuller; Douglas A Brooks; John J Hopwood
Journal:  Mol Genet Metab       Date:  2006-04-04       Impact factor: 4.797

9.  Improved assay for differential diagnosis between Pompe disease and acid α-glucosidase pseudodeficiency on dried blood spots.

Authors:  Shohei Shigeto; Tatsuya Katafuchi; Yuya Okada; Kimitoshi Nakamura; Fumio Endo; Torayuki Okuyama; Hiroaki Takeuchi; Marian A Kroos; Frans W Verheijen; Arnold J J Reuser; Toshika Okumiya
Journal:  Mol Genet Metab       Date:  2011-01-22       Impact factor: 4.797

10.  Comparison of maltose and acarbose as inhibitors of maltase-glucoamylase activity in assaying acid alpha-glucosidase activity in dried blood spots for the diagnosis of infantile Pompe disease.

Authors:  Haoyue Zhang; Helmut Kallwass; Sarah P Young; Cortney Carr; Jian Dai; Priya S Kishnani; David S Millington; Joan Keutzer; Yuan-Tsong Chen; Deeksha Bali
Journal:  Genet Med       Date:  2006-05       Impact factor: 8.822

View more
  1 in total

1.  Advantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing Process.

Authors:  Rosita Zakaria; Katrina J Allen; Jennifer J Koplin; Peter Roche; Ronda F Greaves
Journal:  EJIFCC       Date:  2016-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.